A real-time RT-PCR for detection of clade 1 and 2 H5N1 Influenza A virus using Locked Nucleic Acid (LNA) TaqMan probes by Tran Tan, Thanh et al.
METHODOLOGY Open Access
A real-time RT-PCR for detection of clade 1 and 2
H5N1 Influenza A virus using Locked Nucleic Acid
(LNA) TaqMan probes
Thanh Tran Tan
1*, Hana Apsari Pawestri
2, Ngoc Nghiem My
3, Hien Vo Minh
3, Harun Syahrial
2, Trung Nguyen Vu
4,
H Rogier van Doorn
1,6, Heiman FL Wertheim
5,6, Chau Nguyen Van Vinh
3, Ha Do Quang
1, Jeremy J Farrar
1,6,
Hien Tran Tinh
3, Endang R Sedyaningsih
2, Menno D de Jong
1,6,7
Abstract
Background: The emergence and co-circulation of two different clades (clade 1 and 2) of H5N1 influenza viruses
in Vietnam necessitates the availability of a diagnostic assay that can detect both variants.
Results: We developed a single real-time RT-PCR assay for detection of both clades of H5N1 viruses, directly from
clinical specimens, using locked nucleic acid TaqMan probes. Primers and probe used in this assay were designed
based on a highly conserved region in the HA gene of H5N1 viruses. The analytical sensitivity of the assay was <
0.5 PFU and 10 - 100 ssDNA plasmid copies. A total of 106 clinical samples (58 from patients infected with clade 1,
2.1 or 2.3 H5N1 viruses and 48 from uninfected or seasonal influenza A virus-infected individuals) were tested by
the assay. The assay showed 97% concordance with initial diagnostics for H5 influenza virus infection with a
specificity of 100%.
Conclusions: This assay is a useful tool for diagnosis of H5N1 virus infections in regions where different genetic
clades are co-circulating.
Background
Highly pathogenic avian influenza A (H5N1) viruses
cause sporadic infections in humans, and are associated
with severe respiratory disease with a mortality of about
60% [1]. Since the re-emergence of human H5N1 influ-
enza virus infections in January 2003 [2], 436 human
cases have been documented in 15 countries in Asia,
Africa, and Europe [1]. Genetic studies have revealed that
most of the viruses isolated from humans and poultry
belong to genotype Z [3,4]. The worldwide distribution
of this genotype has resulted in the establishment of at
least two genetically and geographically distinct clades:
clade 1 and 2 [5]. Clade 1 H5N1 viruses have been iso-
lated from poultry and humans in Vietnam, Thailand,
and Cambodia, and from poultry in Laos and Malaysia
[6-8]. Clade 2 viruses have a larger genetic diversity and
are divided into 5 sub-clades (2.1 to 2.5) [9]. Clade 2.1
viruses have been found only in Indonesia, in poultry and
humans [6]. Clade 2.2 viruses have caused poultry out-
breaks and human infections in the Middle East, Africa,
and Europe [1]. Clade 2.3 viruses are further divided into
four sub-clades (2.3.1 to 2.3.4) [9]. Recently, clade 2.3.4
viruses have become predominant in China and have also
been reported in Hong Kong, Laos, Malaysia, Thailand,
and North-Vietnam [10,11].I nV i e t n a m ,c l a d e s1a n d
2.3.4 co-circulate among poultry and have both caused
human infections [11,12].
The circulation of more than one virus clade poses a
challenge for laboratory diagnostics, since methods for
detection of H5N1 infection usually rely on clade specific
amplification of the HA gene [13-15]. Although rapid
antigen tests, virus isolation, and serological tests can be
used to diagnose H5N1 infection across all clades, these
methods have limited use for routine diagnostics because
of the inability to subtype, the low sensitivity, and the
requirement of biosafety level 3 laboratory facilities. The
accepted reference method for diagnosis of H5N1 infec-
tion is real-time RT-PCR (rRT-PCR) [16]. Compared to
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cross-contamination, higher sensitivity and specificity,
and shorter per sample laboratory turnaround time. Sev-
eral rRT-PCR assays for H5N1 detection have been
described [15,17-20], but only two of them have been
specifically designed for the detection of both clades
[19,20]. In addition, clinical evaluation has not been per-
formed for most of these assays [15,18-20].
Recently, the locked nucleic acid (LNA) technology
has been integrated into real-time PCR, enabling a more
flexible primer and probe design and improving amplifi-
cation efficiency [21-23]. In this study, we describe the
use and evaluation of an LNA TaqMan rRT-PCR for
detection of clade 1 and 2 H5N1 viruses in a large num-
ber of clinical specimens (n = 58).
The assay described here has been established within
the laboratories of the South East Asia Infectious Dis-
ease Clinical Research Network [24] to serve as a sup-
plementary diagnostic test in addition to the FDA -
approved USCDC assay [25] for Influenza virus infection
and H5N1 subtyping.
Results
Analytical sensitivity and specificity
The analytical sensitivity of our LNA Taqman rRT-PCR
for the detection of the HA gene of H5N1 was < 0.5
PFU of virus and 10 copies of ssDNA plasmids. No
fluorescence was detected when analyzing human seaso-
nal H1N1 (n = 4) and H3N2 (n = 5) virus isolates and
non-H5 avian viruses (n = 5), indicating a high specifi-
city for influenza A viruses of subtype H5.
Evaluation of sensitivity and specificity in clinical
specimens
The sensitivity of the assay was clinically evaluated in 58
human specimens, previously confirmed to contain
clade 1, clade 2.1, or clade 2.3 H5N1 virus by virus iso-
lation and/or H5N1 specific RT-PCRs [25,26] and
sequencing (our unpublished data). Our assay detected
H5 virus in 56 of these samples (97%). The sensitivity
was 100% for clade 1 and clade 2.3, and 92% for clade
2.1 (Table 1).
The specificity of the assay in clinical specimens was
assessed by analyzing influenza A H1 or H3 positive
samples (n = 19) and influenza negative (n = 29)
respiratory samples. All of these samples were negative
indicating 100% specificity.
Discussion
Recent evidence of co-circulation of clade 1 and clade 2
H5N1 viruses in South East Asia has highlighted the
need for RT-PCR assays that allow detection of both
genetic clades. We developed a single step rRT-PCR
assay using an LNA TaqMan probe for direct detection
in clinical samples of HA g e n e sf r o mb o t hc l a d e so f
H5N1 viruses. This assay was shown to be sensitive,
specific, and rapid (approximately 3.5 hours after RNA
extraction).
The primers and probe used in this study were
designed to target a highly conserved region in the HA
gene of H5N1 viruses; to ensure amplification of both
clade 1 and 2 RNA, one and two degenerated bases
were incorporated into the forward and reverse primers,
respectively. As the binding efficiency of the original
TaqMan probe was inadequate, LNA residues were
incorporated that result in a tighter crosslink than nor-
mal nucleotides. Incorporation of LNA residues has no
consequences for PCR conditions [27] but is a practical
way to improve probe-binding efficiency [28].
The assay was shown to be sensitive, detecting 10
copies of ssDNA plasmid, and less than 0.5 PFU of
H5N1 viruses per reaction, and specific for the detection
of influenza A of subtype H5. The HA gene of clades 1,
2.1, and 2.3 was amplified from both virus isolates and
human clinical specimens. Cross-reaction with virus iso-
lates from other influenza A subtypes was not observed,
and no positive results were obtained when analyzing 48
clinical samples from patients with either seasonal influ-
enza or non-influenza respiratory illness.
Clinical evaluation was performed on 58 stored clini-
cal specimens from 39 patients infected with either
clade 1, 2.1 or 2.3 viruses and showed high concordance
when compared to initial diagnostic RT-PCR and/or cell
culture results. To our knowledge, the number of H5
positive clinical specimens used in this study is larger
than in any other previously published assays [17].
Our assay has not been evaluated in clade 2.2 H5N1
viruses and clinical specimens. However, in silico analy-
sis of clade 2.2 viruses showed that the primers and
probe used this assay would hybridize sufficiently with
viruses of this sub-clade to allow amplification (data not
shown).
Our assay failed to detect virus in a nasal swab and a
throat swab (Table 1). This may be due to RNA degra-
dation during long-term storage and multiple freeze-
thaw cycles.
Table 1 H5N1 clinical samples and rRT-PCR results
Samples/virus
clade
NS TS TA Plas PF Stool Total rRT-PCR
positive
Clade 1 2 7 1 0 0 0 10 10
Clade 2.1 7 17 1 0 0 0 25 23
Clade 2.3 5 7 6 2 2 1 23 23
Total 14 31 8 2 2 1 58 56
rRT-PCR positive 13 30 8 2 2 1 56
NS = Nasal swab; TS = Throat swab; TA = Tracheal aspirate; Plas = Plasma; PF
= Pleural fluid.
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We have developed a highly sensitive and specific rRT-
PCR assay for the detection of H5N1 influenza A virus
of both clade 1 and 2 directly in clinical specimens, and
evaluated it with a large number clinical samples. Using
this assay, reliable diagnostic results can be obtained in
a few hours, thus enabling timely clinical management
and outbreak control.
Methods
Cell-lines and isolates
For sensitivity and specificity analyses, the following
virus isolates were used: 12 clade 1 human H5N1
viruses, isolated from patients admitted to the Hospital
for Tropical Diseases, Ho Chi Minh City, Viet Nam in
2004 and 2005 [29]; 4 clade 2.3.4 H5N1 viruses isolated
from patients admitted to the National Institute of
Infectious and Tropical Diseases, Ha Noi, Vietnam in
2007 and 2008; 1 human clade 2.1 H5N1 isolate (A/
Indonesia/5/2005(H5N1)), kindly provided by The
National Institute of Infectious Diseases, Tokyo, Japan; 9
human influenza A viruses of subtype H1N1 (n = 4)
and H3N2 (n = 5), isolated from patients with seasonal
influenza from Dong Thap Province, Vietnam, in 2006;
and 7 avian influenza viruses of subtypes H3 (n = 1), H4
(n = 3), H5 (n = 2), and H6 (n = 1), isolated from poul-
try in 2006 in Ho Chi Minh City, and the southern Viet-
namese provinces of Vinh Long, and Dong Thap.
All viruses were cultured in Madin Darby Canine Kid-
ney cells (ECACC, Wiltshire, UK) and were subtyped
using previously described methods [26,30].
Clinical samples
Fifty-eight clinical samples from 39 H5N1-infected
patients were used in this study (Table 1), including
nasal swabs (n = 14), throat swabs (n = 31), nasopharyn-
geal aspirates (n = 8), stools (n = 1), plasma (n = 2), and
pleural fluids (n = 2). Swabs were collected in viral
transport medium and stored at -80°C. Initial diagnoses
in these patients were made independently in Jakarta,
Ha Noi, and Ho Chi Minh City by RT-PCR and/or virus
isolation using previously described methods [26,25].
The samples were collected from patients with H5N1
infection in Indonesia (clade 2.1; 25 specimens from 25
patients) and Vietnam (clade 1; 10 specimens from 10
patients; clade 2.3.4: 23 specimens from 4 patients)
between 2004 and 2008 (Table 1).
Nineteen throat swab samples from 19 patients with
seasonal influenza (seasonal H1N1: n = 10; H3N2: n =
9), confirmed by conventional RT-PCRs and/or virus
isolation as described previously [26], and 29 throat
swab samples from 29 patients with non-influenza
respiratory illness admitted to the Hospital for Tropical
Diseases Ho Chi Minh City during the H5N1 outbreaks
of 2004 - 2005 were also used in this study.
All laboratory analyses in specimens from Indonesian
patients for this study were performed at the National
Institute of Health Research and Development, Ministry
of Health, Jakarta, Indonesia; analyses of specimens
from Vietnamese patients were done at the Hospital for
Tropical Diseases, Ho Chi Minh City, Vietnam.
Ethical approval
Clinical specimens from H5N1 patients in Ho Chi Minh
City and negative control specimens were obtained as
part of studies on H5N1 and respiratory infections that
were approved by the institutional review board of the
Hospital for Tropical Diseases, Ho Chi Minh City, and
the Oxford Tropical Research Ethical Committee.
Informed consent was obtained from all participating
patients or their parents or legal guardians.
The clinical specimens from Indonesian patients and
from patients from Ha Noi were obtained by health care
providers from suspected H5N1 cases as part of the
national procedures for Avian Influenza case investiga-
tion which were exempted from review by the institu-
tional review boards.
RNA extraction
Viral RNA was extracted from 140 μl of clinical samples
or from 50 μl of culture supernatant and eluted in 60 μl
elution buffer using QIAamp Viral RNA Mini kit (Qia-
gen, West Sussex, UK) according to the manufacturer’s
instructions.
Primer and probe design
Nucleotide sequences of all available full length HA
g e n e so fH 5 N 1v i r u s e s( N=3 1 3 )w e r er e t r i e v e df r o m
Influenza Virus Resource [31] and were aligned using
BioEdit version 7.0.1 (Ibis Biosciences, Carlsbad, CA,
USA). Primers and probe were designed using Primer
Express version 2.0 (Applied Biosystems Inc., Foster
C i t y ,C A ,U S A ) .T h ep r o b ew a sf u r t h e rm o d i f i e du s i n g
LNA residues. Primers and probes (Table 2) were
synthesized by Sigma-Proligo, Singapore.
Table 2 Primers and probe used in this study
Name Sequence
a Nucleotide
b
Sense 5’-TTGGTTACCATGCAAACAAYT-3’ 91-111
Antisense 5’-TRTCTTGGGCRTGTGTAACA-3 152-171
Probe 5’-FAM-CAGGTTGACACAATAATGGAAAAG-
BHQ3-3’
119-143
a Y = T or C, R = A or G. LNA residues in the probe are indicated in bold. 5’ -
FAM = 5’ - carboxyfluorescein, BHQ = Black Hole Quencher.
b The position in
the HA gene is indicated.
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For determination of analytical sensitivity, a representa-
tive clade 1 (strain A/Vietnam/CL115/2005(H5N1)) was
titrated in MDCK cells, and serial dilutions at concen-
trations of 10
4 -1 0
-2 PFU/μl were made. From each
resulting dilution, viral RNA was extracted and sub-
jected to rRT-PCR.
In addition, sensitivity analyses were performed as fol-
lows: PCR products from amplification of the HA gene
of A/Vietnam/CL115/2005(H5N1) were purified using
the QIAquick® PCR purification kit (Qiagen), and were
cloned into pCR2.1-TOPO plasmid, and were then used
for transformation of E. coli TOP 10 cells (Invitrogen,
Carlsbad, CA, USA). The plasmids derived from a single
bacterial colony were sequenced using CEQ Dye Termi-
nator Cycle Sequencing Kit (Beckman Coulter, Fuller-
ton, CA, USA). Selected clones were propagated in
liquid LB medium according to the manufacturer’s
instructions and plasmids were purified using QIAprep®
Miniprep Kit (Qiagen). After linearization using XhoI
(New England Biolabs, Ipswich, UK), DNA concentra-
tion was determined spectrophotometrically (NanoDrop
1000, Thermo Scientific, Wilmington, DE, USA). The
plasmids were then diluted tenfold in TE (10
5 -1 0
-2
copies/μl) and were used in analytical sensitivity tests.
All experiments were done in duplicate.
Real-time RT-PCR
Real-time RT-PCR was performed using iScript™ One-
Step RT-PCR Kit Probes in Chromo 4 real time PCR
machines (Bio-Rad, Hercules, CA, USA). The reaction
was conducted in a total volume of 25 μl containing
12.5 μl of 2× RT-PCR Reaction Mix, 400 nM of each
primer, 120 nM of probe, 0.5 μl of iScript Reverse Tran-
scriptase, and 5 μl of template. Optimized rRT-PCR
conditions were as follows: one cycle of 50°C for 15
minutes, followed by 5 minutes at 95°C, and 45 cycles
of 15 seconds at 95°C and 1 minute at 53°C.
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